Discrepancies between prespecified and reported outcomes

Annals of Internal Medicine

Volumn 164, Issue 5, 2016, Pages 374-

  Slade, Eirion ^a   Drysdale, Henry ^a   Goldacre, Ben ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; EVIDENCE BASED MEDICINE; INTERNAL MEDICINE; LETTER; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; BLOOD; DRINKING BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; WINE;

GLUCOSE BLOOD LEVEL; LIPID;

ALCOHOL DRINKING; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPIDS; MALE; WINE;

EID: 84959308893     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/L15-0614     Document Type: Letter

References (4)

1. Gepner Y, Golan R, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Shelef I, et al. Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: a 2-year randomized, controlled trial. Ann Intern Med. 2015;163:569-79. [PMID: 26458258] doi:10.7326/M14-1650
2. The Cardiovascular Diabetes and Ethanol (CASCADE) trial. ClinicalTrials .gov: NCT00784433. Accessed at https://clinicaltrials.gov/ct2/show/NCT0078 4433 on 9 November 2015.
3. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. [PMID: 20332511] doi:10.1136/bmj.c869
4. Centre for Evidence-Based Medicine Outcome Monitoring Project. Tracking switched outcomes in clinical trials. Accessed at www.COMPare-Trials.org on 9 November 2015.